These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

258 related articles for article (PubMed ID: 5664995)

  • 21. [The effect of Halidor in peripheral vascular disorders].
    Braun P; Meskó E; Décsy J
    Orv Hetil; 1968 May; 109(21):Suppl:26-8. PubMed ID: 5720718
    [No Abstract]   [Full Text] [Related]  

  • 22. [1035 M.D. in neurologic accidents of vascular origin].
    Fénelon J
    J Med Bord; 1967 Dec; 144(12):1898-902. PubMed ID: 5622080
    [No Abstract]   [Full Text] [Related]  

  • 23. [On the question of the conservative therapy of stenosis forming and obliterating vascular processes in carotid-vertebral circulatory region].
    Wenker H
    Acta Neurochir (Wien); 1967; 16(3):317-8. PubMed ID: 6059176
    [No Abstract]   [Full Text] [Related]  

  • 24. Medical therapy in arterial disorders of the extremities: Vasodilator drugs.
    Myers KA
    Mod Treat; 1967 Mar; 4(2):370-85. PubMed ID: 5341885
    [No Abstract]   [Full Text] [Related]  

  • 25. [On the treatment of cerebral and peripheral arterial obliterating vascular disorders with Tebonin].
    Gau HP
    Arztl Forsch; 1969; 23(3):103-11. PubMed ID: 5819754
    [No Abstract]   [Full Text] [Related]  

  • 26. [Treatment of vascular diseases of the nervous system with Viquidil hydrochloride].
    Boudouresques J; Gosset A
    Mars Med; 1972; 109(6):453-6. PubMed ID: 4563604
    [No Abstract]   [Full Text] [Related]  

  • 27. [Our experience in the treatment of peripheral vascular diseases with raubasine].
    Vercellio G; Costantini S; Giulini S
    Minerva Cardioangiol; 1972 Apr; 20(4):217-30. PubMed ID: 5023726
    [No Abstract]   [Full Text] [Related]  

  • 28. [Indications for Ustimon and Instenon therapy in cerebrovascular diseases].
    Eichhorn O
    Wien Klin Wochenschr; 1967 Jan; 79(4):67-71. PubMed ID: 5340281
    [No Abstract]   [Full Text] [Related]  

  • 29. [Combined treatment of peripheral perfusion disorders with vasodilators and physiotherapy].
    Baitsch G; Baitsch R
    Munch Med Wochenschr; 1968 Oct; 110(42):2456-63. PubMed ID: 5755166
    [No Abstract]   [Full Text] [Related]  

  • 30. [Results of a clinical study on the vasodilator 3,7-dimethyl-1-(5-oxo-hexyl)-xanthine (BL 191)].
    Lehrach F; Müller R
    Arzneimittelforschung; 1971 Aug; 21(8):1171-4. PubMed ID: 5110012
    [No Abstract]   [Full Text] [Related]  

  • 31. [Current problems in the pharmacotherapy of vascular diseases].
    Cahn J
    Minerva Med; 1976 May; 67(25):1621-7. PubMed ID: 934517
    [No Abstract]   [Full Text] [Related]  

  • 32. [Cerebrovascular-dilator agents].
    Goto F
    Nihon Rinsho; 1970 Mar; 28 Suppl():718-21. PubMed ID: 5430850
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluation of Cinnarizine in patients with peripheral vascular diseases].
    Simões Neto E
    Hospital (Rio J); 1971 Jan; 79(1):189-98. PubMed ID: 5316651
    [No Abstract]   [Full Text] [Related]  

  • 34. [Experience with Vadilex in the treatment of cerebral vascular insufficiency].
    Mizon JP; Gentit F
    Lille Med; 1973 Feb; 18():Suppl 2:229-30. PubMed ID: 4147371
    [No Abstract]   [Full Text] [Related]  

  • 35. [Therapeutic experiences with an adenosine-theophylline Sodium-nicotinate combination in peripheral circulation disorders].
    Weber G; Vogel A
    Dermatol Wochenschr; 1967 Nov; 153(46):1278-82. PubMed ID: 5588908
    [No Abstract]   [Full Text] [Related]  

  • 36. [On the therapy of peripheral circulatory disorders with the new angioactivator Tebonin of plant origin].
    Krammer F
    Med Welt; 1966 Jul; 28():1524-8. PubMed ID: 5984513
    [No Abstract]   [Full Text] [Related]  

  • 37. [Sureptil in cerebrovascular pathology].
    Collard M; Jeanmaire H; Pfrunner G
    Rev Otoneuroophtalmol; 1969 Apr; 41(3):155-7. PubMed ID: 5348265
    [No Abstract]   [Full Text] [Related]  

  • 38. [Vasodilator agents].
    Bollinger A
    Schweiz Med Wochenschr; 1967 Sep; 97(37):1225-7. PubMed ID: 4874428
    [No Abstract]   [Full Text] [Related]  

  • 39. [From clinical medicine to experimentation: cerebral vascular accidents, a new field for the use of a coronarodilator, carbochromene].
    Giovannoni L
    Therapeutique; 1969; 45(6):685-6. PubMed ID: 5398595
    [No Abstract]   [Full Text] [Related]  

  • 40. [Action of MD 1035 in peripheral vascular manifestations].
    Barraine R; Efthymiou TP; Marcantoni JP
    Presse Med (1893); 1970 Dec; 78(53):2389-90. PubMed ID: 5489156
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.